RxDoctor Payments Data

Candice Fox

Nurse Practitioner · Corbin, KYNPI 1417591918

Payments from drug & device makers

$2,309in general payments, 2019–2025

Across 105 payments — averaging $21.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$532
  • Medtronic$456
  • AbbVie$316
  • AstraZeneca$270
  • Pfizer$128
  • Lilly USA, LLC$100
  • plus $506 from 15 others

What the payments were for

  • Food & beverage$2,309100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,309 in reported general payments places this provider in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide77$94,752
EliquisApixaban79$71,738
FarxigaDapagliflozin Propanediol54$53,767
LinzessLinaclotide47$44,531
MounjaroTirzepatide35$38,356
JanuviaSitagliptin Phosphate34$27,126
XareltoRivaroxaban22$21,510
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$18,843
VraylarCariprazine Hcl13$18,711
JardianceEmpagliflozin19$18,237
TrulicityDulaglutide15$18,068
EntrestoSacubitril/Valsartan13$14,016
Janumet XrSitagliptin Phos/Metformin Hcl14$10,195
MultaqDronedarone Hcl11$8,636
Tresiba Flextouch U-100Insulin Degludec12$7,855

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$532$94,75277 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$270$78,02899 claims
PfizerEliquis$128$71,73879 claims
AbbVieLinzess, Vraylar$316$63,24260 claims
Lilly USA, LLCMounjaro, Trulicity$100$56,42550 claims
MerckJanuvia, Janumet Xr$32$37,32148 claims
Johnson & JohnsonXarelto$32$21,51022 claims
Boehringer IngelheimJardiance$61$18,23719 claims
NovartisEntresto$18$14,01613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →